William Petros
William Petros
Professor of Basic Pharmaceutical Sciences, West Virginia University
Verified email at
Cited by
Cited by
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release
G Kong, G Anyarambhatla, WP Petros, RD Braun, OM Colvin, D Needham, ...
Cancer research 60 (24), 6950-6957, 2000
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.
WP Peters, M Ross, JJ Vredenburgh, B Meisenberg, LB Marks, E Winer, ...
Journal of Clinical Oncology 11 (6), 1132-1143, 1993
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with …
A Dowlati, K Robertson, M Cooney, WP Petros, M Stratford, J Jesberger, ...
Cancer research 62 (12), 3408-3416, 2002
Irinotecan therapy in adults with recurrent or progressive malignant glioma
HS Friedman, WP Petros, AH Friedman, LJ Schaaf, T Kerby, J Lawyer, ...
Journal of Clinical Oncology 17 (5), 1516-1516, 1999
Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
MS Anscher, WP Peters, H Reisenbichler, WP Petros, RL Jirtle
New England Journal of Medicine 328 (22), 1592-1598, 1993
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow
JP Stevenson, M Rosen, W Sun, M Gallagher, DG Haller, D Vaughn, ...
Journal of Clinical Oncology 21 (23), 4428-4438, 2003
Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma
M Li, SK Cushing, J Zhang, S Suri, R Evans, WP Petros, LF Gibson, D Ma, ...
ACS nano 7 (6), 4967-4976, 2013
Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors
ML Hauck, SM LaRue, WP Petros, JM Poulson, D Yu, I Spasojevic, ...
Clinical Cancer Research 12 (13), 4004-4010, 2006
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion
GM Beasley, RP Petersen, J Yoo, N McMahon, T Aloia, W Petros, ...
Annals of surgical oncology 15, 2195-2205, 2008
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer
WP Petros, PJ Hopkins, S Spruill, G Broadwater, JJ Vredenburgh, ...
Journal of clinical oncology 23 (25), 6117-6125, 2005
Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer
SW Wilczynski, JJ Erasmus, WP Petros, JJ Vredenburgh, RJ Folz
American journal of respiratory and critical care medicine 157 (2), 565-573, 1998
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects
MV Relling, J Cherrie, MJ Schell, WP Petros, WH Meyer, WE Evans
Clinical Pharmacology & Therapeutics 50 (3), 308-313, 1991
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin‐oxidation and N‐acetylation phenotypes in children
WE Evans, MV Relling, WP Petros, WH Meyer, J Mirro Jr, WR Crom
Clinical Pharmacology & Therapeutics 45 (5), 568-573, 1989
Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support
J Rabinowitz, WP Petros, AR Stuart, WP Peters
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
American journal of respiratory and critical care medicine 161 (1), 17-25, 2000
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel
MC Cox, J Low, J Lee, J Walshe, N Denduluri, A Berman, MG Permenter, ...
Clinical cancer research 12 (15), 4636-4640, 2006
Effects of tobacco smoking and nicotine on cancer treatment
WP Petros, IR Younis, JN Ford, SA Weed
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (10 …, 2012
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
WL Furman, DL Fairclough, RD Huhn, CB Pratt, N Stute, WP Petros, ...
Journal of clinical oncology 9 (6), 1022-1028, 1991
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer
AJ Armstrong, P Creel, J Turnbull, C Moore, TA Jaffe, S Haley, W Petros, ...
Clinical Cancer Research 14 (19), 6270-6276, 2008
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic …
RE Martell, BL Peterson, H Cohen, WP Petros, KR Rai, VA Morrison, ...
Cancer chemotherapy and pharmacology 50, 37-45, 2002
The system can't perform the operation now. Try again later.
Articles 1–20